Lupin share price NSE, Lupin result Q2 2023: Lupin shares rose on Thursday, November 9, as much as 1.7 per cent to clock a fresh 52-week high of Rs 1,232.1 apiece on the NSE, surpassing an earlier peak of Rs 1,224.9 touched yesterday, November 8, after India's second-largest drugmaker by market value impressed the Street with a 3.77-fold YoY jump in its net profit for the September quarter of the current fiscal (Q2 FY24). The result was released post-market hours on Wednesday.

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

Lupin shares ended 0.59 per cent lower at Rs 1,204 on NSE.. The drugmaker reported a 277.6 per cent year-on-year (YoY) rise in consolidated net profit at Rs 489.7 crore for the July-September quarter of the current financial year. The company had reported a profit of Rs 129.7 crore in the year-ago period.
Lupin's revenue from operations came in at Rs 49,392.3 crore, up 20.7 per cent from the year-ago quarter figure of Rs 40,911.6 crore.

The company's earnings before interest, taxes, depreciation, and amortisation (EBITDA) came in at Rs 958.2 crore, up 104.8 per cent from Rs 468 crore logged in the year-ago period. The EBITDA margin was 19.4 per cent against 11.4 per cent in the year-ago period.

Income Statement highlights – Q2 FY2024

  • Personnel cost was 17.4 per cent of sales at INR 8,607 mn compared to INR 844.4 crore in Q1 FY2024
  • Manufacturing and other expenses were 31.4 per cent of sales at INR 1,552 crore compared to INR 1,472,4 crore in Q1 FY2024
  • Investment in R&D for the quarter was INR 376.4 mn (7.6 per cent of sales)

For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com